| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |